Marijuana Stocks & Public Companies

Marijuana Business Stock Ticker

Chris Walsh  | April 30, 2015
More than 100 marijuana stocks are currently listed on NASDAQ. Click to see our chart of the most relevant ones.

Week in Review: OH Lawmakers Okay MMJ, Nasdaq says No to MassRoots & MMJ for Vets

John Schroyer  | May 27, 2016

By John Schroyer and Omar Sacirbey

Ohio lawmakers pass a medical marijuana bill in a bid to undercut a ballot measure, MassRoots’ Nasdaq listing is nixed again, and Congress moves to give military veterans easier access to medical cannabis.

Here’s a closer look at several notable developments in the marijuana industry over the past week.

Nasdaq Shoots Down MassRoots for Stock Listing

John Schroyer  | May 24, 2016

Denver-based MassRoots, the popular social network for cannabis enthusiasts, failed again to secure a public listing on the Nasdaq, a setback for marijuana companies hoping to trade on a major U.S. stock market.

MassRoots said in a press release the Nasdaq linked its decision to the argument that the company, as a pro-marijuana business, could be …

AmeriCann Invests $6.7M in Massachusetts MJ Facilities

Omar Sacirbey  | April 14, 2016

AmeriCann, a Denver medical marijuana company, is investing nearly $7 million in a dispensary and a grow facility in two southern coastal Massachusetts towns, according to the Taunton Gazette.

The cultivation technology and real estate company is under contract to purchase a nearly 1 million-square-foot site for a medical marijuana grow and processing facility …

MassRoots Taking Another Stab at Nasdaq Listing

Omar Sacirbey  | April 11, 2016

MassRoots, the popular social network for cannabis enthusiasts, is taking another shot at getting listed on the Nasdaq.

The Colorado-based company filed an S-1 registration form on Monday with the Securities and Exchange Commission to raise up to $6.5 million by selling shares and warrants – a key part of the process for getting listed on the …

GW Pharmaceuticals Could Make Major Splash in U.S. Cannabis Industry

Omar Sacirbey  | March 30, 2016

By Omar Sacirbey

A British company that develops cannabis-based medicine is on the verge of a major breakthrough that could ripple across the U.S. marijuana industry.

GW Pharmaceuticals will likely seek FDA approval in the fourth quarter of this year to sell an epilepsy drug derived from marijuana, according to an analyst who follows the company.

Study Results Send GW Pharma’s Stock Soaring

Omar Sacirbey  | March 14, 2016

A British maker of cannabis-based drugs revealed some sorely needed good news on Monday, announcing that an epilepsy medicine it created has successfully treated a severe form of epilepsy in children, according to Reuters.

In a clinical study, GW Pharmaceuticals said its Epidiolex syrup reduced the monthly number of seizures in children with Dravet’s …

Oakland Dispensary Shares To Be Publicly Traded

Omar Sacirbey  | January 13, 2016
By Omar Sacirbey

Following a brutal 2015 for marijuana stocks, the cannabis investment sector has something to smile about to start the new year. The stock markets will soon welcome a U.S. dispensary to the ranks of the publicly traded: Black Oak Gallery, better known as Blüm Oakland.

Chart of the Week: Cannabis Stocks End 2015 With Bumps, Bruises

Becky Olson  | January 11, 2016

By Becky Olson

Last year was a tumultuous one for cannabis stocks, further deterring institutional investors from getting involved in a notoriously high-risk sector.

A sampling of 12 stocks analyzed by Marijuana Business Daily started the year off strong, collectively rising about 27% during the first few weeks of 2015.

Medicine Man Technologies Nears Stock Listing

Omar Sacirbey  | December 24, 2015

Medicine Man Technologies, a Colorado-based cannabis consulting firm tied to the family behind two high-profile marijuana stores, received clearance from the Financial Industry Regulatory Authority on Tuesday to become a publicly traded company.

Its shares will trade on the over-the-counter markets, possibly as soon as mid-January, according to company founder and chief operating officer Brett Roper.